Skip to content
News Flash
From Solstice to Sustained Action: The Evolution of the Alzheimer’s Association’s Fundraising Movement

From Solstice to Sustained Action: The Evolution of the Alzheimer’s Association’s Fundraising Movement

on July 9, 2026
Posted by
Grifols Advances Paradigm Shift in Alpha-1 Antitrypsin Deficiency Treatment with Phase 3 SWIFT-SC Trial Launch

Grifols Advances Paradigm Shift in Alpha-1 Antitrypsin Deficiency Treatment with Phase 3 SWIFT-SC Trial Launch

on July 9, 2026
Posted by
The Silent Epidemic: Why Cardiovascular-Kidney-Metabolic (CKM) Syndrome Is the Next Frontier in Public Health

The Silent Epidemic: Why Cardiovascular-Kidney-Metabolic (CKM) Syndrome Is the Next Frontier in Public Health

on July 9, 2026
Posted by
Accountability or Concession? Inside the Federal Settlement with Chemours Over ‘Forever Chemicals’

Accountability or Concession? Inside the Federal Settlement with Chemours Over ‘Forever Chemicals’

on July 9, 2026
Posted by
Scaling the Silence: Ognomy Secures $20 Million to Transform the Future of Sleep Medicine

Scaling the Silence: Ognomy Secures $20 Million to Transform the Future of Sleep Medicine

on July 9, 2026
Posted by
The End of "Always-On": New Moisture-Activated Battery Serves as a Physical Kill Switch for IoT Surveillance

The End of "Always-On": New Moisture-Activated Battery Serves as a Physical Kill Switch for IoT Surveillance

on July 9, 2026
Posted by
Pearl Health Secures $110 Million to Scale AI-Driven Value-Based Care Revolution

Pearl Health Secures $110 Million to Scale AI-Driven Value-Based Care Revolution

on July 9, 2026
Posted by
Health Recovery Support
Health Recovery Support
Health Recovery Support
Health Recovery Support
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy
  • TOS

What are You Looking For?

Trending News

From Solstice to Sustained Action: The Evolution of the Alzheimer’s Association’s Fundraising Movement

From Solstice to Sustained Action: The Evolution of the Alzheimer’s Association’s Fundraising Movement

on July 9, 2026
Posted by
Grifols Advances Paradigm Shift in Alpha-1 Antitrypsin Deficiency Treatment with Phase 3 SWIFT-SC Trial Launch

Grifols Advances Paradigm Shift in Alpha-1 Antitrypsin Deficiency Treatment with Phase 3 SWIFT-SC Trial Launch

on July 9, 2026
Posted by
The Silent Epidemic: Why Cardiovascular-Kidney-Metabolic (CKM) Syndrome Is the Next Frontier in Public Health

The Silent Epidemic: Why Cardiovascular-Kidney-Metabolic (CKM) Syndrome Is the Next Frontier in Public Health

on July 9, 2026
Posted by
Accountability or Concession? Inside the Federal Settlement with Chemours Over ‘Forever Chemicals’

Accountability or Concession? Inside the Federal Settlement with Chemours Over ‘Forever Chemicals’

on July 9, 2026
Posted by
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy
  • TOS
© All rights reserved. Proudly powered by WordPress. Theme NewsCurve designed by WPInterface.
Tags
#zymeworks#zuidgeest#zuffa#zubir#zones#zone
  • Home
  • disease
  • Page 3

disease

89 posts
The Silent Signal: Why Women with Cardiovascular Disease Need Earlier Conversations About Sleep-Disordered Breathing
Posted in Sleep Health

The Silent Signal: Why Women with Cardiovascular Disease Need Earlier Conversations About Sleep-Disordered Breathing

on June 25, 2026
Beyond Diabetes: Experimental Drug IC7Fc Shows Promise as a Multimodal Weapon Against Cardiovascular Disease
Posted in Cardiovascular Recovery

Beyond Diabetes: Experimental Drug IC7Fc Shows Promise as a Multimodal Weapon Against Cardiovascular Disease

on June 24, 2026
The Nutritional Frontier: How Kidney Filtration and Methionine Could Rewrite the "Disease Trajectory"
Posted in Nutrition and Recovery

The Nutritional Frontier: How Kidney Filtration and Methionine Could Rewrite the "Disease Trajectory"

on June 24, 2026
The Intersection of Obesity, Chronic Disease, and COVID-19: A Multifaceted Public Health Challenge
Posted in Nutrition and Recovery

The Intersection of Obesity, Chronic Disease, and COVID-19: A Multifaceted Public Health Challenge

on June 23, 2026
Beyond the Straight Line: Texas A&M Researchers Revolutionize Vascular Disease Modeling with "Living" Vessel-Chips
Posted in Cardiovascular Recovery

Beyond the Straight Line: Texas A&M Researchers Revolutionize Vascular Disease Modeling with "Living" Vessel-Chips

on June 23, 2026
The Silent Crisis: Why Cardiovascular Disease in Women is Approaching a Tipping Point by 2050
Posted in Cardiovascular Recovery

The Silent Crisis: Why Cardiovascular Disease in Women is Approaching a Tipping Point by 2050

on June 23, 2026
The Silent Opponent: Public Health Officials Brace for Disease Outbreaks During the World Cup
Posted in Caregiver Support

The Silent Opponent: Public Health Officials Brace for Disease Outbreaks During the World Cup

on June 22, 2026
Bionyra Pharma Enters the Immunology Fray: A $165 Million Bet on the Next Generation of Inflammatory Disease Treatment
Posted in Digital Health Tools

Bionyra Pharma Enters the Immunology Fray: A $165 Million Bet on the Next Generation of Inflammatory Disease Treatment

on June 22, 2026
The Invisible Threat: New Research Links Microplastic Exposure to Accelerated Heart Disease
Posted in Cardiovascular Recovery

The Invisible Threat: New Research Links Microplastic Exposure to Accelerated Heart Disease

on June 19, 2026
Beyond Diabetes: Experimental Drug IC7Fc Shows Promise in Combatting Cardiovascular Disease
Posted in Cardiovascular Recovery

Beyond Diabetes: Experimental Drug IC7Fc Shows Promise in Combatting Cardiovascular Disease

on June 16, 2026

Posts navigation

← Older Articles
Newer Articles →

Recent Posts

  • From Solstice to Sustained Action: The Evolution of the Alzheimer’s Association’s Fundraising Movement
  • Grifols Advances Paradigm Shift in Alpha-1 Antitrypsin Deficiency Treatment with Phase 3 SWIFT-SC Trial Launch
  • The Silent Epidemic: Why Cardiovascular-Kidney-Metabolic (CKM) Syndrome Is the Next Frontier in Public Health
  • Accountability or Concession? Inside the Federal Settlement with Chemours Over ‘Forever Chemicals’
  • Scaling the Silence: Ognomy Secures $20 Million to Transform the Future of Sleep Medicine

Recent Comments

No comments to show.
© All rights reserved. Proudly powered by WordPress. Theme NewsCurve designed by WPInterface.
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy
  • TOS